Diastolic dysfunction can precede systolic dysfunction on MUGA in cancer patients receiving trastuzumab-based therapy

BACKGROUND: Trastuzumab (T) and anthracycline (A)-based chemotherapy is considered the standard of care in human epidermal growth factor receptor-2+ overexpressing breast cancer, but requires monitoring for known cardiotoxicity using left ventricular (LV) ejection fraction (EF) every 3–4 months duri...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Ran, Nadouri, Doaa, Osler, Erin, Johnson, Christopher, Dent, Susan, Dwivedi, Girish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282666/
https://www.ncbi.nlm.nih.gov/pubmed/30418380
http://dx.doi.org/10.1097/MNM.0000000000000941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282666/
https://www.ncbi.nlm.nih.gov/pubmed/30418380
http://dx.doi.org/10.1097/MNM.0000000000000941

Ejemplares similares